NLRP3 and colitis: Wencheng Wei et al. found that Sirt1 signaling blocked the NLRP3-initiated cascade to increase expression of tight junction proteins, occludin and ZO-1, to ameliorate colonic epithelial dysfunction in experimental colitis [32].